PART 15

SUPPLEMENTARY

Panels

Panels constituted to decide applications: general provision
297
1
In this section “panel” means a panel constituted under—
a
Schedule 1 (applications for authorisation);
b
Schedule 3 (applications for extension of period of authorisation);
c
Schedule 6 (applications for extension of period of public protection order without restrictions).
2
A panel must have 3 members (all of whom must be present during any proceedings of the panel). , all of whom must be present during any proceedings of the panel, except where—
a
the panel does not hear oral evidence,
b
each of the members provides a written opinion, and
c
the decision of the panel is unanimous.
3
Regulations may make further provision about the membership or procedure of panels, including—
a
provision requiring panels to give prescribed persons the opportunity to make representations;
b
provision enabling a panel to request prescribed persons to provide information to the panel or attend before the panel to give oral evidence;
c
provision about steps that a panel is, or is not, to be regarded as required by section 7 to take where it has to make a determination of what would be in a person's best interests;
d
provision for cases where a panel cannot reach a unanimous decision.
4
The Department may by regulations amend any of the following—
a
the definition of “the permitted period” in paragraph 19(2) of Schedule 1;
b
any period mentioned in paragraph 20(2)(b) or (3)(b) of that Schedule;
c
the definition of “the permitted period” in paragraph 9(2) of Schedule 3;
d
the definition of “the permitted period” in paragraph 9(2) of Schedule 6.
S. 297 in operation at 2.12.2019 for specified purposes by S.R. 2019/163, art. 2(4), Sch. Pt. 4 (with art. 3) (as amended by S.R. 2019/190, art. 2)
Words in s. 297(2) substituted (temp.) (2.4.2020) by virtue of Coronavirus Act 2020 (c. 7), s. 87(2), Sch. 11 para. 3 (with ss. 88-90, Sch. 11 para. 2); S.R. 2020/58, art. 2(e)
S. 297(2) expiry of earlier affecting provision 2020 c. 7, Sch. 11 paras. 3-9 (25.3.2022) by Coronavirus Act 2020 (c. 7), s. 89 (with s. 90)